History and progress of hypotheses and clinical trials for Alzheimer’s disease

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Autophagy: Renovation of Cells and Tissues

Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,615

Autophagy fights disease through cellular self-digestion

Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226

IDH1 and IDH2 Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847

A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Frontiers In Traumatic Brain Injury

Lv, X., Guo, Y., & Mao, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98165

Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint

Murphy, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/7gsaz

Introduction

Dereli, F. T. G., & Belwal, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819212-2.00009-8

Identifying new COVID-19 receptor Neuropilin-1 in severe Alzheimer’s diseases patients group brain using genome-wide association study approachPreprint

Lim, K., Yang, S., Kim, S.-H., & Joo, J. (2021) · Research Square · doi:10.21203/rs.3.rs-143798/v1

Applications of Nanotechnology in Alzheimer’s Disease

Chountoulesi, M., Naziris, N., Gioran, A., Papagiannopoulos, A., Steele, B. R., Micha‐Screttas, M., Stavrinides, S. G., Hanias, M. P., Chondrogianni, N., Pispas, S., et al. (2022) · Springer eBooks · doi:10.1007/978-3-319-75479-6_16-1

Alzheimer׳s Disease: One of the Pandemics of the 21st Century

Cortés‐Canteli, M., & Pérez‐Castillo, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00247-9

AD Blank Spot Model for Evaluation of Alzheimer’s Disease

Avramouli, A., & Vlamos, P. (2023) · Springer eBooks · doi:10.1007/978-3-319-75479-6_58-1

White matter alterations in amnestic mild cognitive impairment: a tract-based spatial statistics study

Çavuşoğlu, B., Ada, E., Emek‐Savaş, D. D., & Yener, G. (2023) · Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi · doi:10.18614/deutip.1135057

Selection of animal models for drug efficacy

Veening-Griffioen, D. H. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1605

Cannabidiol-Mediated Sequestration of Alzheimer’s Amyloid-β Peptides in ADDL Oligomers

Li, Y., Zhang, F., Herron, C. E., Rosales, I., Heredia, A., Buchete, N., & Rodriguez, B. J. (2023) · American Journal of Molecular Biology · doi:10.4236/ajmb.2023.132008

Ablation of cell-specific cholesterol synthesis affects cerebral β-amyloidosis

Spieth, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9780

Cromeno[3,4-b]xantonas: Novos Inibidores da Acetilcolinesterase e Agregação Beta-amiloide

Malafaia, D., Oliveira, A. C. M., Fernandes, P. A., Ramos, M. J., Albuquerque, H. M. T., & Silva, A. M. S. (2023) · Boletim da Sociedade Portuguesa de Química · doi:10.52590/m3.p705.a30002637

Neurological Applications of Magnetic Resonance-Guided Focused Ultrasound Therapy

Ahmed, A.-K., Gandhi, D., Miller, T. R., Gullapalli, R. P., & Melhem, E. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_57

Investigating the Mammillary Bodies as an Early Target of Alzheimer's Disease

Martinson, C. (2023) · doi:10.15760/honors.1428

The Amyloid Cascade Hypothesis Has to Deliver, Finally

Behl, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31570-1_15

Alternative Hypotheses and Observations that Were Somehow Lost on the Way

Behl, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31570-1_17

AD Blank Spot Model for Evaluation of Alzheimer’s Disease

Avramouli, A., & Vlamos, P. (2023) · Springer eBooks · doi:10.1007/978-3-319-75922-7_58

Potential Linkages between Alzheimer’s Disease and Major Depression

Raudino, F. (2023) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_65_22

Book Review: Alzheimer's Disease Research: What has guided research so far and why it is high time for a paradigm shift (Christian Behl. Springer Nature, Switzerland, 2023) 661 pp.

Turner, A. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15989

Modern approaches to pharmacotherapy of Alzheimer's disease

Davydov, G. S., & Геннадьевна, Ф. С. (2023) · Scientific Bulletin of the Omsk State Medical University · doi:10.61634/2782-3024-2023-9-31-40

Fluorescent Organic Molecules as Diagnostic and Theranostic Tools for Alzheimer’s Disease

Imran, K., Dhamapurkar, Y. A., & Sharma, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_5

Investigation of banana peel powder in scopolamine induced neurobehavioral changes in zebrafish model

Gupta, S., Hugar, S., Patil, V. P., Awasthi, S., Hugar, L., & Hanakuntimath, N. (2024) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2024.01.23.1110

The Role and Therapeutic Potential of α-secretase in Alzheimer’s Disease

Peddapalli, V., & van Oosten‐Hawle, P. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i4.5752

Prophylactic and therapeutic inhalation of two essential oils ameliorates scopolamine-induced cognitive impairment in mice

Wang, W., Yang, J., Liang, D., Yao, L., & Ma, L. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2334335

(outdated draft) Somatostatin and the pathophysiology of Alzheimer’s diseasePreprint

Almeida, V. N. (2024) · Qeios · doi:10.32388/goy6dk.2

GRK5KO Mouse Mirrors Mild Cognitive Impairment due to Alzheimer’s DiseasePreprint

Suo, W. Z. (2024) · Preprints.org · doi:10.20944/preprints202404.0829.v1

On-scalp magnetoencephalography: an innovative technology for patients with neurological pathologies

Feys, O., Tombroff, L., & Tiège, X. D. (2024) · Revue Medicale de Bruxelles · doi:10.30637/2024.23-048

A Short Review on Nutritional Management of Alzheimer Disease

Barde, M. S. R. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.63797

MLR-1023 Improves Cognition Deficiency and Oxidative Stress in Lipopolysaccharide-Induced Mice Model of Alzheimer’s Disease: Role of PPAR-gamma Receptors and NO-cGMP-KATP Channels Pathway

Dolatshahi, M., Hayay, Y., Mard‐Soltani, M., Paridar, Y., & Nazarinia, D. (2024) · Journal of Advanced Immunopharmacology · doi:10.5812/jai-149170

Molecular Modeling Insights on the Pharmaceuticals and Hypotheses of Alzheimer’s Disease

de Castro, A. A., Silva, H. F., Garcia, M. V. F. P., Homem‐de‐Mello, P., & Ramalho, T. C. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673318143240823064403

Advanced drug delivery systems in the management of CNS disorders

Bidaliya, V., Alam, M. R., Bhratee, A., Kumar, M., Anand, P., Chawla, P. A., & Singh, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00020-2

Toxic Tau Aggregation in AD

Zaafar, D. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_43

Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and beyond

Li, S., & Kang, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223910124090003

Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes

Kurban, B., Osmani̇ye, D., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2024) · Polycyclic aromatic compounds · doi:10.1080/10406638.2024.2442581

Apolipoprotein E ε4 exacerbates microglia-mediated complement-dependent synapse loss caused by neuronal Tpk deficiencyPreprint

Du, P., Jin, B., Wang, Z., Zhao, B., Sang, S., & Zhong, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633468

DHPMs C5 Amide Bearing Benzothiazole Moiety Inhibit AChE: Design, Synthesis, In Vitro and In Silico Studies

Samiei, P., Dastan, D., & Ebadi, A. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162025010285

Alzheimer Hastalığının Patogenezinde Sideritis L. (Dağçayı) Türlerinin Biyokimyasal ve Moleküler Etkileri

Değirmenci, U. (2025) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1555225

Co-Deposited Proteins in Alzheimer’s Disease as a Potential Treasure Trove for Drug Repurposing

Apostolakou, A. E., Douska, D. E., Litou, Z. I., Trougakos, I. P., & Iconomidou, V. A. (2025) · Molecules · doi:10.3390/molecules30081736

Copper-Aβ and cytochrome c: a potential Janus in Alzheimer's disease

Dey, C., Pal, P., Ghosh, R., & Dey, S. G. (2025) · Dalton Transactions · doi:10.1039/d5dt01594d

WITHDRAWNPreprint

(2025) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/jy3st_v7

WITHDRAWNPreprint

(2025) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/jy3st_v8

Combating Lead/HFD Neurotoxicity in Rats: The Synergistic Effect of 10-Hydroxydecanoic Acid and Zinc Oxide Nanoparticles

Saleh, S. R., Atef, E., Maher, A. M., Ghareeb, D. A., Sheta, E., & Eweda, S. M. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04764-1

Les métaux sont-ils le chaînon manquant pour comprendre la maladie d’Alzheimer ?

Vitale, N., Faller, P., Hureau, C., & Okafor, M. (2022) · doi:10.64628/aak.4j93acxtm

Computational Insights into Dopamine-Mediated Conformational Transitions of Aβ Aggregates in Alzheimer’s Disease

Swain, S., & Metya, A. K. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00456

Clinical profiles and diagnostic trends in Alzheimer's disease: A retrospective observational study

Sakhri, F. Z., Sakhri, A., Daci, F., Chine, M. E., & Lakhdari, N. (2025) · Romanian Journal of Neurology · doi:10.37897/rjn.2025.3.3

Alzheimer’s Disease: Engaging with an Unstable Category

Daly, T. P., & Keuck, L. (2025) · Springer eBooks · doi:10.1007/978-94-024-2252-8_113

Targeting Amyloid Toxicity: Novel Cholinesterase Inhibitors Protect Hippocampal Cells from Amyloid Peptide-Derived Death

Buloyan, S. A., Poghosyan, A., Harutyunyan, H. A., Yeritsyan, H., Sargsyan, M., Hovhannisyan, A. A., Topuzyan, V. O., & Gasparyan, H. V. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04592-8

Alzheimer’s Disease: Pathophysiological and Therapeutical Insights

Tyagi, K., Sarup, P., & Malik, J. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_1 · Cited by 1

In silico decoding strategic pathways inhibition by coptisine for halting Alzheimer’s pathology: a mechanistic insight

Roy, A., Kumar, D., Bhattacharya, P., & Borah, A. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00473-8

The Role of c-Abl in Alzheimer’s Disease: Guilty or not Guilty?

Li, W., Wang, X., Liu, J., & Chen, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01650-1

Methyl eugenol as a multitarget-directed ligand for Alzheimer disease: A promising lead for drug design

Aiswarya, N., Remya, C., Sajitha, K., Rajan, R., Vasudevan, D. M., & Dileep, K. V. (2025) · ASPET Discovery · doi:10.1016/j.aspetd.2025.100019

Deep learning analysis of urine-derived stem cell mitochondrial morphology as a non-invasive Alzheimer’s disease biomarker

Yan, R., Zhang, W., Wang, W., Wu, J., Zhang, J., Xu, Y., Xu, W. F., & Yang, W. K. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00813

Additional file 8 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751314

Additional file 3 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751299

Additional file 2 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751296

Additional file 2 of Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice

Cutuli, D., Landolfo, E., Nobili, A., Bartolo, P. D., Sacchetti, S., Chirico, D., Marini, F., Pieroni, L., Ronci, M., D’Amelio, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245943

Additional file 2 of Effects of different kinds of anti-Alzheimer’s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials

Lyu, D., Gong, M., Zhang, Y., & Lyu, X. (2022) · Figshare · doi:10.6084/m9.figshare.19695834

Additional file 1 of Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges

Wu, C., Yang, L., Feng, S., Zhu, L., Yang, L., Liu, T. C., & Duan, R. (2022) · Figshare · doi:10.6084/m9.figshare.21259535

Additional file 5 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751305

Additional file 9 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751317

Additional file 4 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751302

Additional file 1 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751293

Additional file 1 of Effects of different kinds of anti-Alzheimer’s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials

Lyu, D., Gong, M., Zhang, Y., & Lyu, X. (2022) · Figshare · doi:10.6084/m9.figshare.19695831

Additional file 1 of K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway

Ham, H. J., Lee, Y. S., Yun, J., Son, D. J., Lee, H. P., Han, S.-B., & Hong, J. T. (2020) · Figshare · doi:10.6084/m9.figshare.13272091

Additional file 10 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751320

Additional file 7 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751311

Additional file 1 of Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice

Cutuli, D., Landolfo, E., Nobili, A., Bartolo, P. D., Sacchetti, S., Chirico, D., Marini, F., Pieroni, L., Ronci, M., D’Amelio, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245940

Additional file 1 of New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation

Ayoup, M. S., Ghanem, M., Abdel-Hamid, H., Abu-Serie, M. M., Masoud, A. A., Ghareeb, D. A., Hawsawi, M. B., Sonousi, A. S. M., & Kassab, A. E. (2024) · Figshare · doi:10.6084/m9.figshare.26748980

Additional file 1 of Subject classification and cross-time prediction based on functional connectivity and white matter microstructure features in a rat model of Alzheimer’s using machine learning

Diao, Y., Lanz, B., & Jelescu, I. (2024) · Figshare · doi:10.6084/m9.figshare.26636694

Additional file 6 of Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway

Wang, Z., Liu, J., Han, J., Zhang, T., Li, S., Hou, Y., Su, H., Han, F., & Zhang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26751308

Drosophila melanogaster as a Powerful Model for Decoding the Molecular Basis of Animal Disease

Oliveira, R., Santos, B., Pereira, L. C., & Costa, T. (2021) · Interdisciplinary Research in Medical Sciences Specialty · doi:10.51847/bejxj7acvl

Recent Advances and Strategies in Drug Repurposing for Alzheimer’s Disease Therapy

Kim, S., Woo, H., Chae, S., & Kim, J. E. (2025) · KSBB Journal · doi:10.7841/ksbbj.2025.40.4.327

Nanotherapeutics for Alzheimer’s Disease with Nanobiomaterials

Gnanasekaran, G. S., Charulekha, K., Basavaraju, P., Mariappan, V., Nagendran, N. A., & Moorthi, P. V. (2026) · Nanotechnology in the life sciences · doi:10.1007/978-3-032-08576-4_5

Neuroprotective Effect of a Nutraceutical Formulated with Pouteria campechiana’s and Lannea microcarpa’s Fruits on Alzheimer’s Disease

Tueguem, G. J. T., Doungue, H. T., Kenfack, J. O., Téné, S. T., Kengne, A. P. N., & Gatsing, D. (2025) · Journal of Food and Nutrition Sciences · doi:10.11648/j.jfns.20251306.15

CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice

Ham, H. J., Park, S. S., Lee, Y. S., Kim, T. H., Son, D. J., Kim, J.-H., Lim, K., Park, H., Lee, H. J., Yun, J., et al. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1728279

Valorization of Olive Oil Residues: Phytochemical Analysis and Potential Bioactivity

Alvarez, C., Bedoya, M., & Gutiérrez, M. (2025) · doi:10.3390/ecsoc-29-26727

The Cross-Species Implantable ATP Battery Inspired by Photosynthesis for Application in Diseases

Chen, M., Zhang, W., Qu, B., & Huang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s569114

Non-viral vasculogenic reprogramming restores cognition and mitigates pathology in Alzheimer’s diseasePreprint

Alzate‐Correa, D., Stranan, J. P., Rincon‐Benavides, M. A., Mazo, N. A., Narváez-Pérez, L. F., Jaramillo-Garrido, S., Nguyen, T., Patel, R., Lawrence, W. R., Diaz‐Starokozheva, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.22.700900

Targeting Intrinsic Neuronal Defense Against Multiple Insults: The “One4More” Therapeutic Strategy for Alzheimer’s Disease

Suo, W. Z. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0012

The crosstalk between blood-brain barrier and neural cells: bidirectional regulation of brain function and pathology

Ju, M., Shen, H., Zhang, X., Tian, M., & Zhang, L. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102475

Remote ischemic conditioning improves neuropsychiatric symptoms in COVID-19 patients: a randomized clinical trial

Wu, Y., Li, M., Li, H., Li, H., Shen, T., Liu, Y., Wang, G., Sun, H., Li, Z., & Zhang, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1674886

Gut Microbiota and Probiotics in Alzheimer’s Disease: Mechanisms, Evidence, and Therapeutic Potential – A Review of Literature

Banasik, M., Adamczyk, A., Ważny, M., Gancarz, A., Żak, A., Gut, M., Toporowska-Kaźmierak, J., Sowińska, M., Tworek, M., & Bezara, D. (2026) · Quality in Sport · doi:10.12775/qs.2026.52.69093

Drugs used in the treatment of Alzheimer’s disease: a review of current clinical research and promising therapeutic targets

Sorokina, K. N., Толстикова, Т. Г., Usov, V. Y., & Тулупов, А. А. (2026) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20260102

オリーブオイル副産物の生理活性：生理活性成分の回収・利用による付加価値創出

Rogers, M. (2020) · Kyushu University Institutional Repository (QIR) (Kyushu University)

Du génome humain au modèle murin : compréhension des ciliopathies

Delvallée, C. (2020) · theses.fr (ABES) · doi:10.70675/09e80c82z8902z406cz811az98cd7652a079

Exploration de nouveaux biomarqueurs plasmatiques pour le diagnostic de la maladie d’Alzheimer

Rossi, E. (2021) · theses.fr (ABES) · doi:10.70675/71230be4z1955z4fafzb1b8z8ff71a4edaff

Taylor dispersion analysis : a powerful size-based characterization technique for monitoring the aggregation of β-amyloid peptides

Deleanu, M. (2022) · theses.fr (ABES) · doi:10.70675/ac5c66b3z37eez4081za67fz47d148570e83

Regulation of Alzheimer pathology by amyloid seeds : from toxic effects to therapeutic opportunities, in mouse model of amyloidosis

Célestine, M. (2023) · theses.fr (ABES) · doi:10.70675/873ca377z9a97z43f6z8051zdab4082686ba

Alzheimer’s disease : epistemology, ethics, innovation

Daly, T. P. (2021) · theses.fr (ABES) · doi:10.70675/6e99838az7dd4z402fz98fdzeca072d3ad13

Die Amyloid-Kaskaden-Hypothese muss endlich liefern

Behl, C. (2026) · Springer eBooks · doi:10.1007/978-3-662-72210-7_15

Alternative Hypothesen und Beobachtungen, die verloren gingen

Behl, C. (2026) · Springer eBooks · doi:10.1007/978-3-662-72210-7_17

NeuroD1 gene therapy converts reactive astrocytes to functional new neurons in a mouse model of Alzheimer’s disease

Chen, S., Li, J., Zhou, J., Xie, W., Li, H., Yang, L., Chen, G., & Long, C. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00721

Computational Design of Azole Derivatives as Multifunctional Agents for Alzheimer's Disease

Puentes‐Díaz, N., Alvarez-Ricardo, Y., Chaparro, D., Flores‐Gaspar, A., Hurtado, J., & Alí‐Torres, J. (2026) · Applied Organometallic Chemistry · doi:10.1002/aoc.70582

Discovery of Eosin Y as a photocatalytic labeling sensor to detect, capture and profile amyloid plaques in Alzheimer's disease brain tissue

Guo, F., Feng, H., Sun, R., Yan, J., Ge, Y., Liu, X., Zhang, X., Zhang, X., Zhang, X., & Liu, Y. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.139961

An interfering peptide attenuates diabetic encephalopathy by blocking the interaction between CD44 and STAT3

Huang, C., Zhang, Q., Wang, X., Xie, Y., Zhou, Y., Yan, C., Wang, K., Zhu, H., Gao, L., Wu, S., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106782

Unraveling the neuroprotective potential of bioactive natural products: Insights from structure–activity studies inAlzheimer's disease

Ugwah-Oguejiofor, C. J., Okechukwu, P. N., Mathias, S. N., Ofokansi, M. N., & Janakiraman, A. K. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49144-3.00007-1

Disc1 Gene Expression as a Blood Biomarker for Major Depressive Disorder: A Comparative Study of Fluoxetine and Cognitive-Behavioral Therapy

Barzegar, A., Pourasghar, M., Hashemi‐Soteh, M. B., Baki, B., & Ghalehnoei, H. (2026) · Neurochemical Journal · doi:10.1134/s1819712426700133

L-α-GPC in Cognitive Decline: Mechanisms and Clinical Evidence in Neurodegenerative Disorders

Putri, V., Hapsari, R., & Amalia, R. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s579603

The bidirectional mechanistic links between Alzheimer’s disease and cardiovascular disease

You, J., & Yang, J. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09151-9

Alzheimer’s Disease: Hypotheses and therapies

Chen, N. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19968

Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses

(2024) · aging and disease · doi:10.14336/ad.2023.0608 · Cited by 183

Recent Clinical Developments in Alzheimer's Disease

(2016) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681082318116050005

Clinical Trials in Alzheimer’s Disease: A Hurdle in the Path of Remedy

Oxford, A. E., Stewart, E. S., & Rohn, T. T. (2020) · International Journal of Alzheimer s Disease · doi:10.1155/2020/5380346 · Cited by 111

Alzheimer’s disease hypothesis and related therapies

Du, X., Wang, X., & Geng, M. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0107-y · Cited by 623